Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Asterion Announces Appointment of Dr. Stewart McGlashan as Director of Project Development

Asterion Announces Appointment Of Dr. Stewart McGlashan As Director Of Project Development

Vancouver, British Columbia--(Newsfile Corp. - November 15, 2018) - Asterion Cannabis Inc. ("Asterion" or the "Company"), announces the appointment of Dr. Stewart McGlashan as the Company's Director of Project Development.

Dr. McGlashan brings over 20 years of experience as a business manager, inventor and investor while operating in a global capacity within the agribusiness, food, energy, engineering, clean technology and environmental sectors. He brings a diverse portfolio of experiences and a unique skill set that applies to challenging projects requiring different approaches to build success and business resilience. Dr. McGlashan has previously taken companies from early-stage development to producing commercial outcomes in the biodegradable plastics, waste-to-energy, renewable fertilizers, waste processing, biofuels and biosecurity technology industries.

Dr. McGlashan is expected to be involved in overseeing, managing, and monitoring Asterion's projects from an executive level.

"We are pleased to have Dr. Stewart McGlashan as a part of our team," said Stephen Van Deventer, Chairman and CEO of the Company. "His comprehensive experience and education, exemplifies leadership and team management within business innovation and transformation. It also demonstrates Dr. McGlashan's proactive and pragmatic development and execution of strategies, where he strives to successfully achieve milestones to meet business needs."

Dr. McGlashan commented, "I am delighted to join an excellent team delivering a project that has the potential to benefit so many lives. I look forward to driving Asterion's projects forward to commercial reality."

About Asterion

Asterion is a Canadian cannabis company with operations in Australia, specializing in organic medical cannabis with a goal of becoming an industry leader in next generation cannabis products. The Company is focused on the future of precision agriculture and aims to produce the highest quality genetically uniform cannabis strains, at an affordable price.

The Company is led by a team of highly experienced executives with over 120 years of combined experience in medical cannabis, renewable energy, capital markets, and other highly relevant sectors across North America, Oceania, Europe, Africa and Asia.

On Behalf of the Board of Directors

"Stephen Van Deventer"
Chief Executive Officer

For further information, please contact:

Deanna Kress
+1-778-999-6063
[email protected]

Forward-Looking Statements:

This news release contains forward-looking statements and forward-looking information (collectively, "forward-looking statements") within the meaning of applicable Canadian and U.S. securities legislation, including the United States Private Securities Litigation Reform Act of 1995. All statements in this news release that are not purely historical are forward-looking statements and include statements regarding beliefs, plans, expectations and orientations regarding the future including, without limitation, the Company's anticipated business plans and its prospect of success in executing its proposed plans. Often, but not always, forward-looking statements can be identified by words such as "plans", "expects", "may", "intends", "anticipates", "believes", "proposes" or variations of such words including negative variations thereof and phrases that refer to certain actions, events or results that may, could, would, might or will occur or be taken or achieved. Actual results could differ from those projected in any forward-looking statements due to numerous factors including, but not limited to, the inability of the Company to execute its proposed business plans and obtain the financing required to carry out its planned future activities. Other factors such as general economic, market or business conditions or changes in laws, regulations and policies affecting the biotechnology or medical cannabis industry and delays in obtaining governmental and regulatory approvals, may also adversely affect the future results or performance of the Company. These forward-looking statements are made as of the date of this news release and, unless required by applicable law, the Company assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in these forward-looking statements. Although the Company believes that the statements, beliefs, plans, expectations, and intentions contained in this news release are reasonable, there can be no assurance that those statements, beliefs, plans, expectations, or intentions will prove to be accurate. Readers should consider all of the information set forth herein and should also refer to other periodic reports provided by the Company from time-to-time.

Readers are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly, are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements.



This post first appeared on Newsfile Corp News Releases, please read the originial post: here

Share the post

Asterion Announces Appointment of Dr. Stewart McGlashan as Director of Project Development

×

Subscribe to Newsfile Corp News Releases

Get updates delivered right to your inbox!

Thank you for your subscription

×